Details checkedClinical trial listing onlyCheckedregistry+institution

BrainGate2 Neural Interface System

Also known as: BrainGate2, BrainGate Neural Interface System, BrainGate BCI, BrainGate clinical BCI

BrainGate Consortium

Primary source

Sponsor / Institution

BrainGate Consortium

Program Type

Software/Neurotech

Modality

BCI/Neurotech

Stage

Interventional/NA

Status

Active

Target Gene

—

Route / Mode

Implanted intracortical neural interface with external neural decoding and assistive-control software

Confidence

88%

Status Confidence

Status needs checking

Evidence Strength

Needs more support

Last Reviewed

2026-06-10

Geography

United States

Population

adult, implantable-bci, intracortical-interface, research-platform, assistive-technology, communication-accessibility

Trial IDs

Mechanism

Investigational implanted neural-interface system that records motor-cortex activity and translates intended movement into cursor, communication, and assistive-device control in people with tetraplegia or severe paralysis.

Indications

Communication Impairment Severe Paralysis Locked-In Syndrome Speech Impairment

Notes

Foundational clinical BCI program, curated separately from the Blackrock NeuroPort product row because BrainGate2 is a long-running investigational clinical-system lineage for communication and assistive control rather than a standalone commercial hardware listing.

Evidence & Sources

3 structured sources

institution

Supports: canonicalName, aliases, company, mechanism, stage, status, route

Open

clinicaltrials

Supports: trialIds, indications, geography, populationTags

IDs: NCT00912041

Open

institution

Supports: notes, mechanism

Open